138 / 1196
PET scans in delineation of lung cancer
•
FDG-PET has an established role in contouring NSCLC
•
Changes the tumor GTV in about 30–60% of patients
•
Changes the nodal GTV in 9–39% of patients mainly through detection
of occult metastases not seen on CT, lowering the risk of nodal
recurrences